Which has higher earnings and valuation, DXCM or MDT?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.10 $836.30M $2.34 31.51 Medtronic $33.54B 2.82 $4.66B $3.59 20.54

Is DXCM or MDT more profitable?

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.00%. DexCom's return on equity of 33.33% beat Medtronic's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 19.31% 33.33% 13.19% Medtronic 13.00% 14.82% 7.88%

Does the media refer more to DXCM or MDT?

In the previous week, DexCom had 8 more articles in the media than Medtronic. MarketBeat recorded 27 mentions for DexCom and 19 mentions for Medtronic. DexCom's average media sentiment score of 1.19 beat Medtronic's score of 0.61 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 22 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Medtronic 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media prefer GEHC or MDT?

In the previous week, Medtronic had 6 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 19 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.28 beat Medtronic's score of 0.61 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media favor MDT or ISRG?

In the previous week, Intuitive Surgical had 29 more articles in the media than Medtronic. MarketBeat recorded 48 mentions for Intuitive Surgical and 19 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.27 beat Medtronic's score of 0.61 indicating that Intuitive Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Intuitive Surgical 39 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ABT or MDT?

In the previous week, Abbott Laboratories had 18 more articles in the media than Medtronic. MarketBeat recorded 37 mentions for Abbott Laboratories and 19 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 0.94 beat Medtronic's score of 0.61 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 26 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Positive Medtronic 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media refer more to BSX or MDT?

In the previous week, Boston Scientific had 37 more articles in the media than Medtronic. MarketBeat recorded 56 mentions for Boston Scientific and 19 mentions for Medtronic. Boston Scientific's average media sentiment score of 0.63 beat Medtronic's score of 0.61 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 28 Very Positive mention(s) 8 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 4 Very Negative mention(s) Positive Medtronic 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Medtronic (MDT) Competitors

$73.73 -1.84 (-2.44%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$74.16 +0.43 (+0.58%)

As of 05/29/2026 07:59 PM Eastern

Compare

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

Should you buy Medtronic stock or one of its competitors? MarketBeat compares Medtronic with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medtronic include DexCom (DXCM), GE HealthCare Technologies (GEHC), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), and Boston Scientific (BSX). These companies are all part of the "medical" sector.

How does Medtronic compare to DexCom?

DexCom (NASDAQ:DXCM) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.00%. DexCom's return on equity of 33.33% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Medtronic	13.00%	14.82%	7.88%

In the previous week, DexCom had 8 more articles in the media than Medtronic. MarketBeat recorded 27 mentions for DexCom and 19 mentions for Medtronic. DexCom's average media sentiment score of 1.19 beat Medtronic's score of 0.61 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	22 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
Medtronic	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

DexCom currently has a consensus target price of $82.42, indicating a potential upside of 11.77%. Medtronic has a consensus target price of $106.45, indicating a potential upside of 44.38%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.10	$836.30M	$2.34	31.51
Medtronic	$33.54B	2.82	$4.66B	$3.59	20.54

DexCom has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

97.8% of DexCom shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

DexCom beats Medtronic on 13 of the 17 factors compared between the two stocks.

How does Medtronic compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

GE HealthCare Technologies has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.37	$2.08B	$4.18	14.91
Medtronic	$33.54B	2.82	$4.66B	$3.59	20.54

Medtronic has a net margin of 13.00% compared to GE HealthCare Technologies' net margin of 9.10%. GE HealthCare Technologies' return on equity of 20.46% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Medtronic	13.00%	14.82%	7.88%

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.9%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Medtronic pays out 79.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies has increased its dividend for 1 consecutive years and Medtronic has increased its dividend for 49 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

GE HealthCare Technologies presently has a consensus price target of $80.21, indicating a potential upside of 28.67%. Medtronic has a consensus price target of $106.45, indicating a potential upside of 44.38%. Given Medtronic's stronger consensus rating and higher possible upside, analysts plainly believe Medtronic is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58

In the previous week, Medtronic had 6 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 19 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.28 beat Medtronic's score of 0.61 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Medtronic beats GE HealthCare Technologies on 12 of the 18 factors compared between the two stocks.

How does Medtronic compare to Intuitive Surgical?

Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Medtronic has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$33.54B	2.82	$4.66B	$3.59	20.54
Intuitive Surgical	$10.06B	14.94	$2.86B	$8.25	51.47

Medtronic presently has a consensus target price of $106.45, suggesting a potential upside of 44.38%. Intuitive Surgical has a consensus target price of $576.71, suggesting a potential upside of 35.83%. Given Medtronic's higher possible upside, research analysts plainly believe Medtronic is more favorable than Intuitive Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Intuitive Surgical has a net margin of 28.15% compared to Medtronic's net margin of 13.00%. Intuitive Surgical's return on equity of 15.98% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.00%	14.82%	7.88%
Intuitive Surgical	28.15%	15.98%	14.07%

In the previous week, Intuitive Surgical had 29 more articles in the media than Medtronic. MarketBeat recorded 48 mentions for Intuitive Surgical and 19 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.27 beat Medtronic's score of 0.61 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Intuitive Surgical	39 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Intuitive Surgical beats Medtronic on 13 of the 16 factors compared between the two stocks.

How does Medtronic compare to Abbott Laboratories?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.35	$6.52B	$3.57	23.91
Medtronic	$33.54B	2.82	$4.66B	$3.59	20.54

Abbott Laboratories has a net margin of 13.90% compared to Medtronic's net margin of 13.00%. Abbott Laboratories' return on equity of 17.62% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Medtronic	13.00%	14.82%	7.88%

In the previous week, Abbott Laboratories had 18 more articles in the media than Medtronic. MarketBeat recorded 37 mentions for Abbott Laboratories and 19 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 0.94 beat Medtronic's score of 0.61 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	26 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Positive
Medtronic	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Abbott Laboratories presently has a consensus price target of $119.09, indicating a potential upside of 39.52%. Medtronic has a consensus price target of $106.45, indicating a potential upside of 44.38%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.88
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Abbott Laboratories has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 3.0%. Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.9%. Abbott Laboratories pays out 70.6% of its earnings in the form of a dividend. Medtronic pays out 79.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 54 consecutive years and Medtronic has raised its dividend for 49 consecutive years.

Summary

Abbott Laboratories beats Medtronic on 16 of the 20 factors compared between the two stocks.

How does Medtronic compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Boston Scientific currently has a consensus target price of $87.46, indicating a potential upside of 81.00%. Medtronic has a consensus target price of $106.45, indicating a potential upside of 44.38%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Boston Scientific is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.86
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58

Boston Scientific has a net margin of 17.29% compared to Medtronic's net margin of 13.00%. Boston Scientific's return on equity of 19.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Medtronic	13.00%	14.82%	7.88%

In the previous week, Boston Scientific had 37 more articles in the media than Medtronic. MarketBeat recorded 56 mentions for Boston Scientific and 19 mentions for Medtronic. Boston Scientific's average media sentiment score of 0.63 beat Medtronic's score of 0.61 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	28 Very Positive mention(s)	8 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	4 Very Negative mention(s)	Positive
Medtronic	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Medtronic has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.58	$2.90B	$2.39	20.22
Medtronic	$33.54B	2.82	$4.66B	$3.59	20.54

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Boston Scientific has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Summary

Boston Scientific beats Medtronic on 12 of the 17 factors compared between the two stocks.

Get Medtronic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDT vs. The Competition

Export

Metric	Medtronic	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$94.76B	$8.29B	$6.58B	$23.19B
Dividend Yield	3.85%	2.54%	2.68%	4.09%
P/E Ratio	20.54	15.85	21.59	30.62
Price / Sales	2.82	8.37	561.77	24.75
Price / Cash	9.52	17.57	27.44	19.43
Price / Book	1.96	3.69	10.04	4.70
Net Income	$4.66B	$224.05M	$3.56B	$1.07B
7 Day Performance	-6.27%	3.72%	2.85%	1.14%
1 Month Performance	-9.06%	4.14%	4.59%	1.26%
1 Year Performance	-11.20%	3.90%	37.62%	28.06%

Medtronic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDT Medtronic	4.8857 of 5 stars	$73.73 -2.4%	$106.45 +44.4%	-11.2%	$94.76B	$33.54B	20.54	95,000	Upcoming Earnings High Trading Volume
DXCM DexCom	4.4199 of 5 stars	$72.10 flat	$82.21 +14.0%	-14.2%	$27.82B	$4.82B	30.81	11,000	Analyst Forecast Insider Trade
GEHC GE HealthCare Technologies	4.9486 of 5 stars	$64.23 flat	$80.21 +24.9%	-10.9%	$29.22B	$20.98B	15.37	54,000	Positive News Insider Trade
ISRG Intuitive Surgical	4.1647 of 5 stars	$438.10 flat	$579.33 +32.2%	-23.0%	$155.16B	$10.06B	53.10	17,021	Trending News Analyst Forecast
ABT Abbott Laboratories	4.9312 of 5 stars	$87.42 +0.0%	$119.43 +36.6%	-36.1%	$152.27B	$45.13B	24.49	115,000	Trending News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MDT) was last updated on 5/31/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Summary

How does Medtronic compare to Intuitive Surgical?

Summary

How does Medtronic compare to Abbott Laboratories?

Summary

How does Medtronic compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Is DXCM or MDT more profitable?

Does the media refer more to DXCM or MDT?

Do analysts rate DXCM or MDT?

Which has higher earnings and valuation, DXCM or MDT?

Which has more risk & volatility, DXCM or MDT?

Do insiders & institutionals believe in DXCM or MDT?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Which has more volatility and risk, GEHC or MDT?

Which has better valuation & earnings, GEHC or MDT?

Is GEHC or MDT more profitable?

Is GEHC or MDT a better dividend stock?

Do analysts rate GEHC or MDT?

Does the media prefer GEHC or MDT?

Do institutionals and insiders believe in GEHC or MDT?

Summary

How does Medtronic compare to Intuitive Surgical?

Which has more volatility and risk, MDT or ISRG?

Which has preferable valuation and earnings, MDT or ISRG?

Do analysts rate MDT or ISRG?

Do institutionals & insiders hold more shares of MDT or ISRG?

Is MDT or ISRG more profitable?

Does the media favor MDT or ISRG?

Summary

How does Medtronic compare to Abbott Laboratories?

Which has better valuation and earnings, ABT or MDT?

Is ABT or MDT more profitable?

Does the media prefer ABT or MDT?

Do analysts rate ABT or MDT?

Do insiders & institutionals have more ownership in ABT or MDT?

Which has more risk & volatility, ABT or MDT?

Is ABT or MDT a better dividend stock?

Summary

How does Medtronic compare to Boston Scientific?

Do analysts recommend BSX or MDT?

Is BSX or MDT more profitable?

Does the media refer more to BSX or MDT?

Which has preferable valuation & earnings, BSX or MDT?

Do insiders & institutionals have more ownership in BSX or MDT?

Which has more risk & volatility, BSX or MDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools